Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

296

HTML

2806

Figures (1-1)

268

Tables (1-14)

252

Sum=3622

Feb 7, 2005 (publication date) through Feb 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 7, 2005; 11(5): 665-671
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.665

Table 13 Effect of bicyclol on ossification of fetus, n (%).

Dosage (mg/kg)	n	Ossification of sternum
Dosage (mg/kg)	n	Defect of the 5th and 6th sternums	Defect of the 6th sternum	Number of sternum defects
Control	87	0	8 (9.2)	79 (91.0)
Bicyclol 200	77	1 (1.3)	6 (7.8)	70 (90.9)
Bicyclol 1000	108	9 (8.3)	1 (0.9)	94 (87.0)

Citation: Liu GT, Li Y, Wei HL, Lu H, Zhang H, Gao YG, Wang LZ. Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study. World J Gastroenterol 2005; 11(5): 665-671
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/665.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i5.665